2. The Respondent, trained as a psychiatrist, is not board-certified in any specialty.
The Respondent has worked as a Medical Director at three facilities since October
2014: from October 2014 through October 2015 at Facility A; from August 2015 through
February 2017 at Facility B; and from January 3, 2017 to September 18, 2017, at
Facility C.'

3. On or about April 26, 2016, the Board received a complaint from two social
workers employed by Facility B, alleging that the Respondent had recommended that a
former patient (“Patient A”) share her prescription for Seroquel? with her minor son.

4. After receiving the complaint, the Board initiated an investigation, and on October
31, 2016, notified the Respondent of its investigation and requested a written response
to the allegations.

5. On or about November 7, 2016, the Respondent, through his attorney, submitted
a written response to the complaint.

6. Board staff subpoenaed the Respondent’s personnel and medical files and
conducted interviews of the Respondent and several witnesses.

7. Following a review of the investigative documents, in furtherance of its
investigation, the Board ordered that the Respondent be evaluated by the Maryland
Professional Rehabilitation Program (“MPRP”), The Respondent met with MPRP on or
about August 21, 2017.

8. On August 28, 2017, as part of MPRP’s evaluation, Dr. A, a neuropsychologist,

evaluated the Respondent.

 

‘in order to maintain confidentiality, facility, patient and employee names will not be used in this document, but
will be provided to the Respondent on request.
Psychotropic medication commonly used in the treatment of bipolar disorder, schizophrenia and
depression.
2
